The report "Dengue Vaccine Market by Product Type (CYD-TDV (Dengvaxia), DENVax, TetraVax-DV, Others), by Vaccine Type (Live Attenuated Vaccine, Killed Vaccine, Others), By End User (Hospitals, Clinics, Government Institutes, Non-Governmental Organizations (NGOs)) - Global Forecasts to 2030", is projected to reach USD 472.6 million in 2023, registering at a Compound Annual Growth Rate...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian